Industry wants more innovation, but can suppliers meet customers' needs?
Downstream Processing
Latest News
Advertisement
Fouling Mechanisms of Filters in the Harvest Development of Monoclonal Antibody Therapeutics—Pt 2
The authors evaluated the potential of direct filtration for multiple biopharmaceutical candidates. This article is Part 2 of the study.
Fouling Mechanisms of Filters in the Harvest Development of Monoclonal Antibody Therapeutics—Pt 1
The authors present a methodology to assess the contribution of individual filters to overall capacity of the direct filtration train, and elucidate how capacity is affected by characteristics of the cell culture broth and process parameters.
Stepping Up Process Control with Single-Use Systems
SUS aids biopharma manufacturers to overcome the rigidity of more traditional stainless-steel technologies.
Advertisement
Panayiotis P. Constantinides of Biopharmaceutical & Drug Delivery Consulting on growth of nanoparticle delivery systems.
A review of key industry shifts and promises for the future.
Industry experts discuss significant achievements. Plus: What's in store for the future.
This article discusses potential opportunities to improve the patient experience through formulation and delivery device technologies.
MAb polishing using salt tolerant interaction membrane chromatography.
Industry experts discuss the benefits and challenges of self-administration of injectable therapies.
A technical rountable featuring Sartorius Stedim Biotech, Pall Life Sciences, 3M Purification, Asahi Kasei Bioprocess, and Bio-Rad Laboratories.
The authors describe a new assembly for bulk and final drug product filling operations.
Demonstration of large-scale stem-cell scale-up.
Recombinant albumin can stabilize a drug product and assist in API release.
Key business considerations when developing biosimilar products virtually.
The authors compare the exposure risk from viable particles from the air supply in four well-established aseptic filling technologies.
Has an approval in oncology reignited interest in the recruitment of the immune system in the fight against disease?
This month, we rewind to "Separations Technology Outlook, Part II: Improved Recovery and Greater Purity."
Approaches for risk assessment of extractables and leachables.
The authors describe a novel means to control ice nucleation using a sterile cryogenic ice fog.
Can a nanofiltration process be leveraged for removal of prions?
Readers react to the economic turmoil of the past year and look longingly forward to 2012.
With careful analysis to mitigate risk, disposable technology and process closure can enable adaptable designs and reduced costs.
An evaluation of the technologies needed to develop a safe, effective, and economically efficient vaccine. This article is part of a special section on vaccines.
Development of the ideal DNA vaccine requires the optimization of delivery strategies and plasmid vectors.
A survey provides insight into drug companies' plans for spending on outsourced services. This article contains bonus online material.
The author reviews the state of downstream processing, including a look at the streamlining of full processes and borrowed technologies.
The author describes recent developments to help overcome the downstream-processing bottleneck.
Advertisement
Advertisement